Remepy, Merck KGaA pair up to test app-paired drug model in rare tumour

April 29, 2026

More like this

Merck KGaA taps into Remepy’s Hybrid Drug platform

The Pharma Letter

Remepy to Collaborate with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas

American Pharmaceutical Review

Merck partners Remepy in PDURS-focused alliance

Pharmaphorum